From fowl plague to influenza pandemic; a reason for taking precautions;Van vogelpest tot influenzapandemie; reden tot voorzorgen

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 10, 2004, Pages 458-463

  Kroes, A C M ^a   Spaan, W J M ^a   Claas, E C J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; VIRUS VACCINE;

ASIA; BIRD DISEASE; DRUG BIOAVAILABILITY; EPIDEMIC; GENE REPLICATION; HUMAN; INFECTION CONTROL; INFECTION RISK; INFECTION SENSITIVITY; INFLUENZA; INFLUENZA VIRUS A; PATHOGENESIS; RECEPTOR SENSITIVITY; REVIEW; VACCINE PRODUCTION; VIRUS INFECTIVITY; VIRUS TYPING;

ANIMALS; CHICKENS; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; ZOONOSES;

EID: 1542374495     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Guan Y, Peiris JS, Lipatov AS, Ellis TM, Dyrting KC, Krauss S, et al. Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR. Proc Natl Acad Sci USA 2002;99:8950-5.
2. Jong JC de, Claas ECJ, Osterhaus ADME. Influenza A(H5N1) in Hongkong: voorbode van een pandemie of alleen een wetenschappelijk interessant verschijnsel en een nuttige oefening in pandemiologie? Ned Tijdschr Geneeskd 1998;142:1252-6.
3. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003;362:1733-45.
4. Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 'Spanish' influenza pandemic. Bull Hist Med 2002;76:105-15.
5. Jong JC de, Rimmelzwaan GF, Fouchier RAM, Osterhaus ADME. Influenzapandemieën: verleden en toekomst. Ned Tijdschr Geneeskd 1999;143:1988-91.
6. Hay AJ. Potential of influenza A viruses to cause pandemics. In: Smith GL, Irving WL, McCauley JW, Rowlands DJ, editors. New challenges to health: the threat of virus infection. Cambridge: Cambridge University Press; 2001. p. 89-104.
7. Claas EC, Osterhaus ADME. New clues to the emergence of flu pandemics. Nat Med 1998;4:1122-3.
8. Galama JMD. Vogelpest en oseltamivir; een terugblik. Ned Tijdschr Geneeskd 2003;147:1100-2.
9. Jong JC de, Osterhaus ADME. Vogelpest en oseltamivir; een terugblik [ingezonden]. Ned Tijdschr Geneeskd 2003;147:1663.
10. Jong JC de, Rimmelzwaan GF, Bartelds AIM, Wilbrink B, Fouchier RAM, Osterhaus ADME. Het influenzaseizoen 2002/'03 in Nederland en de vaccinsamenstelling voor het seizoen 2003/'04. Ned Tijdschr Geneeskd 2003;147:1971-5.
11. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA 2004;101:1356-61.
12. Claas EC, Osterhaus ADME, Beek R van, Jong JC de, Rimmelzwaan GF, Senne DA, et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998;351:472-7.
13. Stevens J, Corper AL, Basler CF, Taubenberger JK, Palese P, Wilson IA. Structure of the uncleaved human Hi hemagglutinin from the extinct 1918 influenza virus. Science [ter perse].
14. Gamblin SJ, Haire LF, Russell RJ, Stevens DJ, Xiao B, Ha Y, et al. The structure and receptor-binding properties of the 1918 influenza hemagglutinin. Science [ter perse].
15. Peiris JS, Guan Y, Markwell D, Ghose P, Webster RG, Shortridge KF. Cocirculation of avian H9N2 and contemporary 'human' H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment? J Virol 2001;75:9679-86.
16. Li KS, Xu KM, Peiris JS, Poon LL, Yu KZ, Yuen KY, et al. Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? J Virol 2003;77:6988-94.
17. Subbarao K, Chen H, Swayne D, Mingay L, Fodor E, Brownlee G, et al. Evaluation of a genetically modified reassortant H5Ni influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 2003;305:192-200.
18. Webster RG. Wet markets - a continuing source of severe acute respiratory syndrome and influenza? Lancet 2004;363:234-6.
19. Webby RJ, Webster RG. Are we ready for pandemic influenza? Science 2003;302:1519-22.
20. Treanor J. Influenza vaccine - outmaneuvering antigenic shift and drift. N Engl J Med 2004;350:218-20.
21. Jong JC de, Beyer WEP, Rimmelzwaan GF, Fouchier RAM, Osterhaus ADME. De neuraminidaseremmers oseltamivir en zanamivir: een nieuw schild in de verdediging tegen influenza. Ned Tijdschr Geneeskd 2004;148:73-9.
22. Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet 2000;355:827-35.
23. Welliver R, Monto AS, Carewicz O, Schatteman E, Hassman M, Hedrick J, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA 2001;285:748-54.
24. Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 2003;326:1235-8.
25. Aoki FY, Macleod MD, Paggiaro P, Carewicz O, El Sawy A, Wat C, et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 2003;51:123-9.
26. Hagenaars TJ, Genugten MLL van, Wallinga J. Het effect van verschillende interventies bij een influenzapandemie. Infectieziekten Bulletin 2004;14:4-6.
27. Whitley RJ, Hayden FG, Reisinger KS, Young N, Dutkowski R, Ipe D, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001;20:127-33.
28. Goudsmit J. De virusinvasie. Over de overleving van virussen en de menselijke soort. Amsterdam: Contact; 2003.
29. We have been warned. Nature 2003;424:113.
30. Cox NJ, Tamblyn SE, Tam T. Influenza pandemic planning. Vaccine 2003;21:1801-3.